Back

Select your region

Schedule a cord blood consultation

Make an appointment

Stem Cells
Therapies

Stem Cells Therapies

The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

Check the full list of patients who received stem cell therapy derived from FamiCord labs.

List last update: 06.2026

List of patients who received stem cells from FamiCord Group laboratories

List of patients who received stem cells from FamiCord Group laboratories
Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
3801 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 32
3802 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 61
3803 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 64
3804 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 10
3805 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 67
3806 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 57
3807 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 55
3808 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 68
3809 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 61
3810 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 17
3811 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 46
3812 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 34
3813 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 39
3814 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 53
3815 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 63
3816 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 22
3817 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 56
3818 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 42
3819 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 66
3820 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 52
3821 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Poland 13
3822 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 32
3823 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 61
3824 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 72
3825 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 55
3826 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 57
3827 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 62
3828 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 46
3829 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 63
3830 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 65
3831 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 71
3832 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 53
3833 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 57
3834 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 50
3835 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 32
3836 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 71
3837 Apheresis Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2021 Standard Therapy Germany 65
3838 Apheresis Autologous Amyloidosis Hematology 2021 Standard Therapy Germany 63
3839 Apheresis Allogeneic Anaplastic Large Cell Lymphoma Hematology 2021 Standard Therapy Germany 56
3840 Apheresis Autologous Angioimmunoblastic T-Cell Lymphoma Hematology 2021 Standard Therapy Germany 62
3841 Apheresis Allogeneic Aplastic Anemia Hematology 2021 Standard Therapy Poland 54
3842 Apheresis Allogeneic Aplastic Anemia Hematology 2021 Standard Therapy Poland 7
3843 Apheresis Allogeneic Aplastic Anemia Hematology 2021 Standard Therapy Poland 40
3844 Apheresis Allogeneic Aplastic Anemia Hematology 2021 Standard Therapy Poland 14
3845 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2021 Standard Therapy Poland 36
3846 Apheresis Autologous B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 59
3847 Apheresis Autologous B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 33
3848 Apheresis Autologous B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 63
3849 Apheresis Autologous B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 49
3850 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2021 Standard Therapy Poland 28
3851 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2021 Standard Therapy Poland 11
3852 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2021 Standard Therapy Poland 62
3853 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2021 Standard Therapy Poland 60
3854 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2021 Standard Therapy Poland 63
3855 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 52
3856 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 45
3857 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 37
3858 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 62
3859 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 64
3860 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 74
3861 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 31
3862 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 63
3863 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2021 Standard Therapy Poland 18
3864 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 68
3865 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 59
3866 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 67
3867 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 62
3868 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 34
3869 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 70
3870 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2021 Standard Therapy Poland 71
3871 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2021 Standard Therapy Germany 67
3872 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2021 Standard Therapy Poland 62
3873 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2021 Standard Therapy Poland 50
3874 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 68
3875 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2021 Standard Therapy Germany 63
3876 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2021 Standard Therapy Germany 65
3877 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2021 Standard Therapy Germany 65
3878 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2021 Standard Therapy Germany 71
3879 Apheresis Allogeneic Farber Disease Hematology 2021 Standard Therapy Poland 9
3880 Apheresis Allogeneic Follicular Lymphoma Hematology 2021 Standard Therapy Poland 54
3881 Apheresis Autologous Follicular Lymphoma Hematology 2021 Standard Therapy Germany 55
3882 Apheresis Autologous Follicular Lymphoma Hematology 2021 Standard Therapy Germany 64
3883 Apheresis Autologous Follicular Lymphoma Hematology 2021 Standard Therapy Germany 50
3884 Apheresis Autologous Germ Cell Tumor Hematology 2021 Standard Therapy Germany 28
3885 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2021 Standard Therapy Poland 23
3886 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 41
3887 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 40
3888 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 27
3889 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 19
3890 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 26
3891 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 32
3892 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 21
3893 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 37
3894 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 30
3895 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 47
3896 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 36
3897 Apheresis Autologous Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 30
3898 Apheresis Allogeneic Hurler Syndrome Hematology 2021 Standard Therapy Poland 2
3899 Apheresis Allogeneic Immunodeficiency Hematology 2021 Standard Therapy Poland 12
3900 Apheresis Allogeneic Leukemia Hematology 2021 Standard Therapy Poland 63